TJX
65
4
NEE
68
11
HON
59
-4
VFC
79
2
AVY
50
3
ADT
48
3
SO
53
-4
CME
45
-3
CL
58
2
LMT
50
3
FITB
73
-2
ABBV
50
-7
DGX
36
-3
ROP
50
3
IVZ
62
-6
PYPL
52
3
PFG
67
2
EIX
53
6
MCK
63
-3
NTAP
67
2
TJX
65
4
NEE
68
11
HON
59
-4
VFC
79
2
AVY
50
3
ADT
48
3
SO
53
-4
CME
45
-3
CL
58
2
LMT
50
3
FITB
73
-2
ABBV
50
-7
DGX
36
-3
ROP
50
3
IVZ
62
-6
PYPL
52
3
PFG
67
2
EIX
53
6
MCK
63
-3
NTAP
67
2
Financhill
Back

Phio Pharmaceuticals Corp. 10K Form

Sell
19

PHIO
Phio Pharmaceuticals Corp.

Last Price:
$1.13
Seasonality Move:
-24.21%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PHIO News And Ratings

See the #1 stock for the next 7 days that we like better than PHIO

PHIO Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-2.1M
Price / Cash Flow: 0
Annual Sales: $1.70
Price / Book: 1.43

Profitability

EPS (TTM): -2.23770
Net Income (TTM): $-8M
Gross Margin: $-35K
Return on Equity: -95.19%
Return on Assets: -83.11%

Phio Pharmaceuticals Corp. Earnings Forecast

Key Phio Pharmaceuticals Corp. Financial Ratios

  • Per Share Earnings over the last 14 years have been positive in 12 years.

Phio Pharmaceuticals Corp. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: PHIO
CUSIP: 71880W
Website: phiopharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 6.9
Quick Ratio: 6.43

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PHIO Technical Analysis vs Fundamental Analysis

Sell
19
Phio Pharmaceuticals Corp. (PHIO) is a Sell

Is Phio Pharmaceuticals Corp. a Buy or a Sell?